Revealing the Membrane-Bound Catalytic Oxidation of NADH by the Drug Target Type-II NADH Dehydrogenase

Journal Article (2019)
Author(s)

Albert Godoy-Hernandez (TU Delft - BT/Biocatalysis)

Daniel J. Tate (The University of Manchester)

D.G.G. McMillan (TU Delft - BT/Biocatalysis, University of Tokyo)

Research Group
BT/Biocatalysis
Copyright
© 2019 A. Godoy Hernandez, Daniel J. Tate, D.G.G. McMillan
DOI related publication
https://doi.org/10.1021/acs.biochem.9b00752
More Info
expand_more
Publication Year
2019
Language
English
Copyright
© 2019 A. Godoy Hernandez, Daniel J. Tate, D.G.G. McMillan
Research Group
BT/Biocatalysis
Issue number
42
Volume number
58
Pages (from-to)
4272-4275
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Type-II NADH:quinone oxidoreductases (NDH-2s) are an important element of microbial pathogen electron transport chains and an attractive drug target. Despite being widely studied, its mechanism and catalysis are still poorly understood in a hydrophobic membrane environment. A recent report for the Escherichia coli NDH-2 showed NADH oxidation in a solution-based assay but apparently showed the reverse reaction in electrochemical studies, calling into question the validity of the electrochemical approach. Here we report electrochemical catalysis in the well-studied NDH-2 from Caldalkalibacillus thermarum (CthNDH-2). In agreement with previous reports, we demonstrated CthNDH-2 NADH oxidation in a solution assay and electrochemical assays revealed a system artifact in the absence of quinone that was absent in a membrane system. However, in the presence of either immobilized quinone or mobile quinone in a membrane, NADH oxidation was observed as in solution-phase assays. This conclusively establishes surface-based electrochemistry as a viable approach for interrogating electron transfer chain drug targets.